Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ashish Dhiman
Observed name:
A Dhiman
Institution:
National Institute of Pharmaceutical Education and Research - Ahmedabad
Observed institutions:
National Institute of Pharmaceutical Education and Research - Ahmedabad,
Maharshi Dayanand University
ORCID:
0009-0009-5341-9394
Observed ORCID:
0009-0009-5341-9394
OpenAlex ID:
A5108483933
A recent update in research on the antihepatotoxic potential of medicinal plants
2012
·
A Dhiman
, Arun Nanda
, et al.
·
Journal of Chinese Integrative Medicine
·
49
Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches
2025
·
Ashish Dhiman
, Yagni Shah
, et al.
·
RSC Pharmaceutics
·
34
PDF
Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies
2024
·
Ashish Dhiman
, Dhwani Rana
, et al.
·
Therapeutic Delivery
·
24
PDF
Leflunomide Applicability in Rheumatoid Arthritis: Drug Delivery Challenges and Emerging Formulation Strategies
2025
·
Ashish Dhiman
, Kalpna Garkhal
·
Drugs and Drug Candidates
·
15
PDF
Reactive Oxygen Species-Mediated Mitochondrial-Targeted Therapeutics in Hepatic Disorders: Current Progress and Future Opportunities
2025
·
Ashish Dhiman
, Yagni Shah
, et al.
·
Molecular Pharmaceutics
·
7
Simultaneous Quantification of Apremilast and Leflunomide Using Reversed Phase High‑Performance Liquid Chromatography Method in Nano‐Liposomal Convoy: Formulation Optimization, Force Degradation Studies, and Greenness Evaluation
2026
·
Ashish Dhiman
, Sachin Chaturvedi
, et al.
·
Separation Science Plus
Extracellular vesicles in the diagnosis of autoimmune diseases
2026
·
Ashish Dhiman
, Kalpna Garkhal
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
8
Citation count:
129
H-index:
5
I10-index:
4
Year
Topic
Type